In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) product approval (Drug Management Division-No. 7934, effective date 2008.07.21), the precautions for use of Roxlin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Roxrin Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Roxlinjeong.hwp9-1. Roxlin Tablet (Precautions for use) (2008.07.21).hwp · 17 KBDownload ↓